Guggenheim Maintains Buy on Tenet Healthcare, Raises Price Target to $307
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $283 to $307.
Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $283 to $307.